KYORIN Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	12,770	7,019	6,906	5,216	8,352
Depreciation & Amortization	4,603	4,290	3,840	3,714	3,564
Loss (Gain) From Sale of Assets	127	90	272	32	-342
Loss (Gain) From Sale of Investments	305	-993	-674	320	-488
Loss (Gain) on Equity Investments	-38	12	-	-25	-49
Other Operating Activities	-1,640	-3,581	1,397	-1,238	-1,895
Change in Accounts Receivable	158	-439	-5,621	-1,226	7,001
Change in Inventory	-12,330	-5,444	-5,809	-3,633	-5,284
Change in Accounts Payable	1,252	319	3,085	3,875	-2,596
Change in Other Net Operating Assets	-1,701	276	-1,388	-689	-3,074
Operating Cash Flow	3,506	1,549	2,008	6,346	5,189
Operating Cash Flow Growth	126.34%	-22.86%	-68.36%	22.30%	-32.95%
Capital Expenditures	-5,697	-5,778	-6,330	-2,444	-4,067
Sale of Property, Plant & Equipment	42	-	100	-	368
Divestitures	-	921	-	-	-
Sale (Purchase) of Intangibles	-596	-468	-3,075	-246	-1,057
Investment in Securities	-52	2,645	3,281	317	632
Other Investing Activities	-20	-507	-251	-187	-135
Investing Cash Flow	-6,323	-3,187	-6,275	-2,560	-4,259
Long-Term Debt Issued	20,000	-	-	-	-
Total Debt Issued	20,000	-	-	-	-
Short-Term Debt Repaid	-2,700	-	-	-	-
Long-Term Debt Repaid	-10,200	-200	-200	-200	-428
Total Debt Repaid	-12,900	-200	-200	-200	-428
Net Debt Issued (Repaid)	7,100	-200	-200	-200	-428
Common Dividends Paid	-3,015	-3,013	-3,015	-3,767	-4,347
Other Financing Activities	-133	-134	-148	-145	-143
Financing Cash Flow	3,952	-3,347	-3,363	-4,112	-4,918
Foreign Exchange Rate Adjustments	-	87	241	139	-43
Miscellaneous Cash Flow Adjustments	-	-31	-83	1	-2
Net Cash Flow	1,135	-4,929	-7,472	-186	-4,033
Free Cash Flow	-2,191	-4,229	-4,322	3,902	1,122
Free Cash Flow Growth	-	-	-	247.77%	-78.06%
Free Cash Flow Margin	-1.68%	-3.54%	-3.82%	3.70%	1.09%
Free Cash Flow Per Share	-38.14	-73.69	-75.42	68.09	19.58
Cash Interest Paid	173	66	66	66	68
Cash Income Tax Paid	1,317	2,975	2,065	1,248	1,899
Levered Free Cash Flow	-5,979	-3,378	-10,346	3,176	-853.13
Unlevered Free Cash Flow	-5,871	-3,336	-10,304	3,218	-810.63
Change in Working Capital	-12,621	-5,288	-9,733	-1,673	-3,953

Source: S&P Global Market Intelligence. Standard template. Financial Sources.